MRK - Merck & Co., Inc.

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5211.26B
Enterprise Value 3230.61B
Trailing P/E 23.14
Forward P/E 115.08
PEG Ratio (5 yr expected) 11.65
Price/Sales (ttm)4.76
Price/Book (mrq)7.66
Enterprise Value/Revenue 35.20
Enterprise Value/EBITDA 613.42

Trading Information

Stock Price History

Beta (3Y Monthly) 0.32
52-Week Change 317.22%
S&P500 52-Week Change 33.10%
52 Week High 387.35
52 Week Low 366.10
50-Day Moving Average 384.73
200-Day Moving Average 381.97

Share Statistics

Avg Vol (3 month) 39.81M
Avg Vol (10 day) 39.57M
Shares Outstanding 52.56B
Float 2.56B
% Held by Insiders 10.08%
% Held by Institutions 178.28%
Shares Short (Aug 15, 2019) 421.83M
Short Ratio (Aug 15, 2019) 42.31
Short % of Float (Aug 15, 2019) 40.85%
Short % of Shares Outstanding (Aug 15, 2019) 40.85%
Shares Short (prior month Jul 15, 2019) 418.94M

Dividends & Splits

Forward Annual Dividend Rate 42.2
Forward Annual Dividend Yield 42.68%
Trailing Annual Dividend Rate 32.06
Trailing Annual Dividend Yield 32.51%
5 Year Average Dividend Yield 43.02
Payout Ratio 459.66%
Dividend Date 3Oct 7, 2019
Ex-Dividend Date 4Sep 13, 2019
Last Split Factor (new per old) 21/2
Last Split Date 3Feb 17, 1999

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 21.10%
Operating Margin (ttm)30.10%

Management Effectiveness

Return on Assets (ttm)9.88%
Return on Equity (ttm)30.55%

Income Statement

Revenue (ttm)44.37B
Revenue Per Share (ttm)17.00
Quarterly Revenue Growth (yoy)12.40%
Gross Profit (ttm)28.81B
EBITDA 17.18B
Net Income Avi to Common (ttm)9.36B
Diluted EPS (ttm)3.57
Quarterly Earnings Growth (yoy)56.40%

Balance Sheet

Total Cash (mrq)7.1B
Total Cash Per Share (mrq)2.78
Total Debt (mrq)27.59B
Total Debt/Equity (mrq)99.46
Current Ratio (mrq)1.21
Book Value Per Share (mrq)10.77

Cash Flow Statement

Operating Cash Flow (ttm)10.81B
Levered Free Cash Flow (ttm)9.63B